2021 Multidisciplinary Oncology Symposium

Sequim, WA US
January 22, 2022

The 2021 Multidisciplinary Oncology Symposium is a one-day conference specifically designed for community oncology providers and other healthcare professionals involved in the care of cancer patients. Expert faculty will review and critically assess the results of practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast, lung, and prostate cancers. We will utilize various strategies to facilitate learning, including case-based panels discussion and an audience response system.

Course Highlights:

  1. Audience response system
  2. Didactics and case-based discussions
  3. Core competencies covered include patient care/patient-centered care, medical knowledge, system-based practice, and practice-based learning and improvement.
  4. Opportunities to network with colleagues and faculty members.
  5. Programs topics can immediately be applied to clinical practice.

Through didactic lectures, case-based presentations, and questions and answer sessions, attendees will be able to learn about the new developments in the field of breast, lung and prostate cancers and have their questions answered. Attendees will also have opportunity to network with faculty if they have questions. The use of audience response system will provide faculty with immediate feedback on attendee’s ability to grasp the presentation and might help clarify topics that need further explanation during the questions and answers session.

Target Audience

  • Medical Oncologists
  • Radiation Oncologists
  • Pulmonologists
  • Pathologists
  • Urologists
  • Internal Medicine/Family Practice
  • NPs/PAs
  • Pharmacists
  • Nurses

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:    

  • Review pertinent clinical trial data for standard of care and novel management strategies for various solid tumors.
  • Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in the standards of care for patients with breast, lung and prostate cancers.
  • Identify side effects, indications, and contra-indications of various therapies used to diagnose and treat breast, lung and prostate cancers, and explain how to effectively manage those side-effects
  • Integrate emerging evidence into treatment paradigms for treatment of patients
Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
  • 0.00 Participation
Course opens: 
12/01/2021
Course expires: 
12/20/2021
Event starts: 
01/22/2022 - 7:30am
Event ends: 
01/22/2022 - 5:05pm
Cost:
$150.00

January 22, 2022

All times are in Pacific Time Zone


06:30 AM – 07:45 AM PST   Registration/Networking

 

07:45 AM – 08:00 AM PST   Welcome

 

08:00 AM – 08:30 AM PST   Advances in (Neo)adjuvant therapies in breast cancer

 

08:30 AM – 09:00 AM PST   Current approach in management of advanced breast cancer

 

09:00 AM – 09:30 AM PST   Case-based panel discussion

 

09:30 AM – 10:00 AM PST   Break

 

10:00 AM – 10:30 AM PST   Targeted (neo)adjuvant therapies in non-small cell lung cancer

 

10:30 AM – 11:00 AM PST   Biomarker-guided treatment of advanced non-small cell lung cancer

 

11:00 AM – 11:30 AM PST   Case-based panel discussion

 

11:30 PM – 01:00 PM PST    Lunch

 

01:00 PM – 01:30 PM PST    Initial management of advanced prostate cancer 

 

01:30 PM – 02:00 PM PST    Management of recurrent prostate cancer

 

02:00 PM – 02:30 PM PST    Case-based panel discussion

 

02:30 PM – 03:00 PM PST    Break

 

03:30 PM – 04:00 PM PST    Updates in management of CLL

 

04:00 PM – 04:30 PM PST    Recent updates in management of diffuse large B cell lymphoma

 

04:30 PM – 05:00 PM PST    Case-based panel discussion

 

05:00 PM – 05:05 PM PST    Adjourn

Holiday Inn
1441 E Washington St
Sequim, WA 98382
United States
Faculty information coming soon.....

 

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 6.0 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6 Contact Hours.

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
  • 0.00 Participation

Price

Cost:
$150.00
Please login or register to take this course.

Physicians (MD/DO) - $150

Non-Physician (RN/NP/PA/PharmD) - $75 

Resident/Fellow - $75


Industry registration

Non-displaying industry representative - $550

Displaying industry representative (not covered by the display fee) - $450 (Displaying reps must register using this link - https://education.binayfoundation.org/industry_registraiton_nocme)

If you are employed by the industry, you must register as "Industry representative" even if you are a licensed healthcare provider not involved in the sales of product. The industry price is applicable to everyone who are employed by an ACCME defined ineligible company.